CSFCX | MGLIX | CSFCX / MGLIX | |
Total Expense Ratio | 1.84 | 0.94 | 196% |
Annual Report Gross Expense Ratio | 1.84 | 0.95 | 194% |
Fund Existence | 21 years | 16 years | - |
Gain YTD | 4.429 | 0.935 | 474% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.94B | 2.26B | 86% |
Annual Yield % from dividends | 1.73 | 2.60 | 66% |
Returns for 1 year | 7.50 | 2.23 | 337% |
Returns for 3 years | 3.18 | -6.29 | -51% |
Returns for 5 years | 30.87 | 20.88 | 148% |
Returns for 10 years | 26.64 | 26.47 | 101% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LIAGX | 14.91 | 0.04 | +0.27% |
Lord Abbett International Growth I | |||
FEUIX | 26.29 | 0.01 | +0.04% |
Fidelity Advisor Glbl Capital Apprec I | |||
VBCVX | 14.37 | -0.01 | -0.07% |
VALIC Company I Systematic Value | |||
IRLSX | 67.34 | -0.06 | -0.09% |
Voya Russell Large Cap Growth Idx Port S | |||
JAGLX | 63.40 | -0.88 | -1.37% |
Janus Henderson Global Life Sciences T |